AcelRx制药

ACRX NASDAQ
2.720
-0.090
-3.20%
盘后: 2.720 0 0.00% 17:04 07/19 EDT
开盘
2.770
昨收
2.810
最高
2.800
最低
2.705
成交量
94.55万
成交均量(3M)
163.32万
52周最高
5.05
52周最低
1.990
换手率
1.20%
市值
2.15亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供AcelRx制药 ACRX股票价格,AcelRx制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

AcelRx Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of moderate-to-severe acute pain. The Company operates through the segment, which includes development and commercialization of product candidates for the treatment of pain. Its lead product candidates include ARX-04, Zalviso, which utilize sublingual sufentanil, delivered through a non-invasive route of administration, and ARX-03. ARX-04 is meant for the treatment of moderate-to-severe acute pain to be administered by a healthcare professional to a patient in medically supervised settings. Zalviso is meant for the management of moderate-to-severe acute pain in hospitalized adult patients. ARX-03 provides mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office. It also includes ARX-02, which is meant for the treatment of patients who suffer from breakthrough pain (BTP) due to cancer.
展开 >

最近浏览

名称
价格
涨跌幅